Pharm Cardio Flashcards
Class 1a
Drugs
Quinidine
Procainamide
Disopyramide.
Class 1a
Drugs:
Quinidine
Procainamide
Disopyramide.
–>MOA
Inhibit Na+ channels= slower depolarization
Inhibit K+ channels =slower rate of repolarization
on atrial & ventricular myocytes cells of the purkinje fibers.
How is moa class 1a different
to class 1b&1c
Work also on Inhibit K+ channels =slower rate of repolarization = lengthen the QT (and QRS )
which mean more likely to cause torsade de point
SE of 1a antiarrhythmics
longer QRS complex and a longer Q-T segment = torsade de pointes
Hypotension
Avoid in HF
Procainamide use & side effect
Type 1a
Rx WWP
SE: SLE
(think caines)
Action of 1B antiarrhythmics
Not as potent in blocking Na+ channel activity
Potency and selectiveness for ischemic tissue, c
Examples 1B antiarrhythmics
(Na channels)
Mexiletine
Lidocaine.
Action of 1C antiarrhythmics
Inhibit the Na+ channels in atrial and ventricular myocytes and purkinje fiber cells.
strongest potency
= dramatic decrease in the slope of phase 0.
Examples 1C antiarrhythmics
Flecainide
Propafenone.
SE 1C antiarrhythmics
- longer QRS complexes
- Avoid in ischemia = sudden death
propafenone is that it causes a bitter or metallic taste
SE: Quinidine
1A ANTIARRYTHMIC
Cinchonism (headache, tinnitus, thrombocytopaenia)
Where are pacemaker cells found
SA node
AV NODE
Bundle of HIS
Na channels on cardiac myocyte control what on ECG
the QRS
hence Na blocker=type 1 antiarrhythmics= prolong qrs
K channels on cardiac myocyte control what on ECG
QT
1a drug long qt = torsade de point
What channels do beta blockers work on and how do they alter myocyte and pacemaker AP
How is this reflected in the ECG
B- blocker decrease Decrease amount of Ca2+ Entering
Pacemaker cells = phase 4 take longer to get to threshold (decrease Rate of contraction)
–> Prolonged PR interval
Decrease amount of Ca2+ Entering Myocyte = affecting phase 2 = decreased force of contraction (recue O2 demand)
Beta blcker effect on DM
decrease hypoglycemia awareness
Beta blker contra indications (3)
pheochromocytoma
Cocaine toxicity
CBB use
What receptor do b-blocker block
B1 adrenergic receptors - g proteins receptors